Longitudinal study for observing the process of informed consent for outpatient chemotherapy

Longitudinal study for observing the process of informed consent for outpatient chemotherapy - Mixed methods Observational Research during Informed Consent process for outpatient chemotherapy (MORE-IC) Act2

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007607

Enrollment

Registered

2012-04-20

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Breast Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients are enrolled in the study if they meet all of the following criteria 1) Written informed consent. 2) They are 20 years old or older. 3) Patients who are eligible for the study by their physicians.

Exclusion criteria

Exclusion criteria: Patients who are disqualified the study by their physicians.

Design outcomes

Primary

Measure	Time frame
Questionnaire of Achievement Motive for Medical Treatment. Subjective score for process of informed consent.	—

Secondary

Measure	Time frame
1) scales regarding self-image. 2) observation record during the IC process, including audio-taped and transcribed data.	—

Countries

Japan

Contacts

Public ContactHatta Taichi

Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital Clinical Inovative Medicine

hatta1@kuhp.kyoto-u.ac.jp075-751-4739

Outcome results